Physician profile
David M Kimble
NPI 1447244868
$10,945.85
in general payments reported to CMS, 2019-2025
9 companies · $1,727 in 2025
The $1,727 reported for 2025 was more than what 81% of Urogynecology and Reconstructive Pelvic Surgery (Obstetrics & Gynecology) providers received nationally (typical 2025 total: $413).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $8,424 · 2020: $23.19 · 2021: $120 · 2022: $534 · 2023: $82.89 · 2024: $34.69 · 2025: $1,727.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $1,107 · Food and Beverage: $738.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $1,106.83 |
| Food and Beverage | $738.13 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Coloplast Corp | $8,555.50 | 2019-2025 | |
| Biotissue Holdings INC. | $1,574.14 | 2025 | |
| Caldera Medical, INC | $525.39 | 2021-2023 | Desara |
| Abbvie INC. | $97.01 | 2022-2025 | |
| Boston Scientific Corporation | $62.63 | 2022-2023 | Upsylon |
| Axonics, INC. | $57.31 | 2022 | |
| Hologic Sales and Service, LLC | $30.95 | 2025 | Thinprep 2000 Processor, Aptima |
| Bayer Healthcare Pharmaceuticals INC. | $23.19 | 2020 | |
| Medline Industries LP | $19.73 | 2025 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw David Kimble listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.